Lipid asymmetry disruption by XKR8 orchestrates neutrophil extracellular trap formation and inhibits fungal infection

Read full text
Authors: Weixiang Liu, Jieming Ping, Lishan Deng, Ke Wang, Jinnuo Xu, Ningxin Peng, Mengyun Yang, Hesen Tang, Zhengjie Liu, Zhengjie Liu, Wenliang Wang, Tao Li
+7 more Jun Xie, Yunyun Han, Zhongjun Dong, Wei Hu, Zheng Liu, Zheng Liu, Ning Wu
Cited by: 3
References: 60

Abstract

Neutrophil extracellular traps (NETs) constitute a vital antimicrobial defense mechanism of neutrophils, contributing to various physio-pathological processes; however, the role of plasma membrane asymmetry in this process remains unknown. Here we identify Xk-related protein 8 (XKR8), a plasma membrane phospholipid scramblase, as a pivotal regulator of NETs formation. Upon NETs induction, XKR8 is cleaved by caspase-3, thereby disrupting plasma membrane lipid asymmetry via phospholipid scrambling. Mutation of the caspase-3 cleavage site in XKR8 impairs NET formation. Inhibition of calcium signals before lipid scrambling abrogates NET formation, whereas blockade after scrambling does not. Cleaved XKR8 reorients plasma membrane lipids, altering membrane lipid tension and promoting Ca2+ signals through mechanosensitive channels. XKR8-deficient mice exhibit compromised NET formation and impaired control of Candida albicans pulmonary infection, showing that XKR8 is indispensable for neutrophil-driven immune responses in vivo. These findings define caspase-3–XKR8plasma membrane phospholipid scrambling as a central mechanism controlling NET formation and underscore its critical role in neutrophil-dependent antifungal immunity. This work shows that XKR8-mediated plasma membrane lipid scrambling facilitates NET formation. Activated by caspase-3, XKR8 links ROS to downstream Ca2+ signaling and is essential for effective antifungal immunity.

Fields of Study & Subjects

Neutrophil Myeloperoxidase and Oxidative Mechanisms Neonatal and Maternal Infections Immune Response and Inflammation

Publication details

Journal / source
Nature Immunology
Publisher
Springer Science and Business Media LLC
Volume
27
Issue
5
Pages
949–960
Publication date
4 March 2026
Language
EN